Current Protein Identity:Q5YD59 New Search
Main Difference Dimensions in This Set
Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
2CM4 The complement inhibitor OmCI in complex with ricinoleic acid Deposited 2006-05-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 19–168(150 aa)
Mutation:YES ACT ACETATE ION × 1 RCL RICINOLEIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.6;30% PEG 4000 0.1 M SODIUM ACETATE PH 4.6 0.2 M AMMONIUM ACETATE
Resolution 1.90 Å
2CM9 The complement inhibitor OmCI in complex with ricinoleic acid Deposited 2006-05-04 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 19–168(150 aa)
Mutation:YES RCL RICINOLEIC ACID × 1 ACT ACETATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 4.6;30% PEG 4000 0.1 M SODIUM ACETATE PH 4.6 0.2 M AMMONIUM ACETATE
Resolution 2.30 Å
3ZUI OMCI in complex with palmitoleic acid Deposited 2011-07-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 19–168(150 aa)
Not recorded PAM PALMITOLEIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% PEG 4000, 0.2 M MGCL2, 0.1 M TRIS PH 8.5.
Resolution 1.71 Å R-free 0.223
3ZUO OMCI in complex with leukotriene B4 Deposited 2011-07-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 19–168(150 aa)
Not recorded LTB LEUKOTRIENE B4 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
Resolution 1.86 Å R-free 0.238
3ZUO OMCI in complex with leukotriene B4 Deposited 2011-07-19 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 19–168(150 aa)
Not recorded LTB LEUKOTRIENE B4 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
Resolution 1.86 Å R-free 0.238
3ZUO OMCI in complex with leukotriene B4 Deposited 2011-07-19 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 19–168(150 aa)
Not recorded LTB LEUKOTRIENE B4 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
Resolution 1.86 Å R-free 0.238
3ZUO OMCI in complex with leukotriene B4 Deposited 2011-07-19 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 19–168(150 aa)
Not recorded LTB LEUKOTRIENE B4 × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.4;21% PEG 4000, 0.2 M SODIUM ACETATE, TRIS 0.1 M PH 8.4.
Resolution 1.86 Å R-free 0.238
5HCC Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Dermacentor andersoni RaCI3. Deposited 2016-01-04 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 19–168(150 aa)
Mutation:N78Q, N102Q EDO 1,2-ETHANEDIOL × 7 CYS CYSTEINE × 1 DIO 1,4-DIETHYLENE DIOXIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9;294 K;10% PEG 20K, 2% v/v 1,4 Dioxane, 0.1 M Bicine pH 9.0
Resolution 2.59 Å R-free 0.267
5HCD Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Rhipicephalus microplus RaCI2 Deposited 2016-01-04 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 19–168(150 aa) Fragment:UNP residues 19-168
Mutation:N78Q, N102Q CYS CYSTEINE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9;294 K;10% (w/v) PEG 20K, 2%(v/v)1,4 Dioxane, 0.1M Bicine pH 9.0
Resolution 2.98 Å R-free 0.282
5HCE Ternary complex of human Complement C5 with Ornithodoros moubata OmCI and Rhipicephalus appendiculatus RaCI1 Deposited 2016-01-04 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 19–168(150 aa) Fragment:UNP residues 19-168
Mutation:N78Q, N102Q CYS CYSTEINE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9;294 K;10% PEG 6K, 0.1 M Bicine pH 9.0
Resolution 3.12 Å R-free 0.281
6RQJ Structure of human complement C5 complexed with tick inhibitors OmCI, RaCI1 and CirpT1 Deposited 2019-05-15 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain C 19–168(150 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å